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Abstract 
PCR was used to amplify the coding region of CHO MCT1 cDNA. This was then used to screen a rat skeletal muscle cDNA library 
which lead to the isolation of a full length cDNA encoding MCT! from rat. The cDNA derived amino acid sequence shows 94% and 86% 
identity to CHO and human MCTI, respectively. 
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The transport of lactate and other monocarboxylic a ids 
such as pyruvate, acetoacetate and /3-hydroxybutyrate is of 
major physiological importance in all mammalian cells. 
Some tissues, such as erythrocytes, turnout cells and white 
skeletal muscle which use glycolysis to provide for their 
ATP requirements, must expel lactic acid from the cell. 
This is also true of cells which are experiencing anoxia. In 
other tissues there is a requirement for lactic acid to be 
transported into cells, either for conversion into glucose by 
gluconeogenic tissues such as the liver and kidney, or for 
utilisation as a respiratory fuel by cardiac and red skeletal 
muscle, (see Ref. [1] for a general review). 
The transport of monocarboxylates across the plasma 
membrane of most mammalian cells utilises a proton-lin- 
ked co-transporter which has been most extensively char- 
acterised in erythrocytes and Ehrlich-Lettr6 tumour cells. 
In these tissues the carrier has been shown to be stereose- 
lective for L-over D-lactate, and sensitive to inhibition by 
derivatives of a-cyanocinnamate, organomercurial thiol 
reagents, and some stilbene disulfonates [2,3]. There is 
increasing evidence that other tissues possess additional 
isoforms of the monocarboxylate cartier, which vary in 
their substrate and inhibitor specificities. This has been 
~' The sequence data reported in this paper have been deposited in the 
EMBL Data Bank under the accession umber X86216. 
* Corresponding author. E-mail: a.halestrap@bristol.ac.uk. Fax: +44 
1117 9288274. 
0005-2736/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2736(95)001  60-3 
demonstrated most clearly in cardiac myocytes [4]. Subtle 
differences in transport properties in some other tissues 
such as liver and skeletal muscle suggest hat these may 
also express additional isoforms [1,5,6]. 
Recently a cDNA encoding MonoCarboxylate Trans- 
porter 1 (MCT1) was cloned from Chinese Hamster Ovary 
(CHO) cells [7]. The cellular distribution of MCT1 in 
various Syrian hamster tissues was studied by Northern 
blotting [8], immunoblotting and immunofluorescence mi-
croscopy [7,9]. The largest amounts of transporter were 
seen in erythrocytes, caecum, heart, eye, lung, epididymis, 
and testis. Intermediate l vels were seen in the brain and 
kidney, while low levels were detected in skeletal muscle 
and liver. Interestingly, the immunofluorescence studies 
demonstrated that only a subset of skeletal muscle fibres 
were immunopositive. These fibres also stained for succi- 
nate dehydrogenase, thus identifying them as mitochondria 
rich. Since both white skeletal muscle and liver are impor- 
tant sites for monocarboxylate transport, hese observations 
provide further evidence for the existence of different 
transporter isoforms. It was therefore decided to clone the 
cDNAs for the skeletal muscle isoforms in order to carry 
out analysis of structure and function. These molecular 
studies were undertaken using rat, since this was the 
experimental system used in most of our previous kinetic 
analyses. The rat is also the animal used most extensively 
in metabolic studies. 
A cDNA probe was generated against he coding region 
of CHO MCT1. Total RNA was prepared from CHO cells 
194 V.N. Jackson et al. / Biochimica et Biophysica Acta 1238 (1995) 193-196 
I C C g I ~  ~ GCGACGTGACT G G T C G G T C ( 3 T G T A G G T G C T ~ C C G G T ~  
92 ~ ~ T T  C G ( : G T ~ C T  - ACACATAACGATACTAGGTTT  C 
182 GCC~C.ATCTTGGAATTCATCGACACCTAAGATGCCACCTGCGATT~ GGGGTACACCCCCCCAGATGGAGGCT~GG 
M P P A 1 G G P V G Y T P P D G G W G W 20 
272 GCGGTGGTAGTTGGAGCCTTCATTTCTATTGGCTTCTCCTATGCATTTCCC.AAATCCAT ACTGTCTTCTTTAAAGAGATT~_~ATA 
A V V V G A F Z 8 I G F 8 Y A F P K 8 I T V F F K E I E I I 50 
362 TTCAGT ~ GTCATGGATATCGTCCATCAT GCTGGCTGT CATGTATGCCGGAGGTCCTAT~ATCTTGGTG 
F 8 A T T S E V 8 W I 8 8 I M L A V M Y A G G P I 8 8 I L V 80 
452 AATAAATAT~CCAGTAATGATTGCTGGT( ]GCTGCCTGTCTGGCTGTGGCTTGATTGC,  A G C T T C T T T C T ~ ~ ~  
N K Y G 8 I% P V M I A G G C L 8 G C G L I A A 8 F C N T V Q I I0 
542 GAACTTTACTTcTGCATTGGTGT~ATTGGAG~TCTTGGGCTTG~-A~F~CAACTTGAACCCAGCTCTGA~TAT~~A~ 
E L Y F C I G V I G G L G L A F N L N P A L T M I G K Y F Y 140 
632 ~TGGCCAATGGCCTGGCTAT GGTGTT CCTCTCTACCCTGGCTCCACTTAAT~CTTTGGT 
K K I% P L A N G L A M A G 8 P V F L S T L A P L N Q A F F G 170 
722 ATTTTTGGCT~TCCTAATTCTTGGG(R]~CTCCT~CTCAA~TGTTGTGTAGCTGGATCCCTGATGCGACCAATAGGGCCT 
I F G W R G 8 F L I L G G L L L N C C V A G 8 L M 1% P I G P 200 
812 ~CCAAAGAGTCTCTCCAGGAAGCTGGGAAGTCTGATGCAAATACAGAT CT CATT GGAGGAAGT 
Q Q G K V E K L K 8 K E 8 L Q E A G K 8 D A N T D L I G G 8 230 
g02 CCC-~-~- a GTCAGTCTTCC-~-~-L-CAGTTAATAAATT CCTGGACTTGTCCCTGTTTACCCAT~TTTTGCT~G 
P K G E K L 8 V F • T V N K F L D L 8 L F T H 1% G F L L Y L 260 
992 TCTGGAAATGTGGTCATGTT~TTTGGGCTCTTT~TGGTCTTT~TTAGTAATTATGGTAAGAGTAAGCATTTTTCC`AGT~ 
8 G N V V M F F G L F T P L V F L 8 N Y G K 8 K H F 8 8 E K 290 
1082 TCAGCCTTCCTCCTTTCCATTTTGGCTTTTGTTGATATGGT ~ C C A T G G G T  GGATCAGACCT 
S A F L L 8 I L A F V D M V A 1% P 8 M G L A A N T R W I R P 320 
I 172 CGAGT cCAGTACTTTTTTG~TGcTT~TGTTGTTG~GAATGGAGTGTGCCATTTG~TGGCAC~-A-~`~*~1TCTA~GA~cTATGTTGGGTT ~ ~ 
R V.. ~ Y F F A A 8 V V A N G V C H L L A P L 8 T T Y V G F C 350 
1262 ATCT~~-~T~'GGATTTGCCTTTGGT T GGCT~CC~TATTGTTT GAGACGTTGATGGACCT GTTGGACCCCJkG~(RT~T C 
I Y A G V F G F A F G W "L 8 8 V L F E T L M D L V G P Q I% F 380 
1352 TCC,~GTGGGCTTGGTGACCATTGTGGAATGT TGTCCTGTCCT C C T ~ T T A G G C C G C C T C A A T G A C A T ~  
S S A V G L V T I V E C C P V L L G P P L L G R L N D M Y G 410 
1442 GACTAC.L_a-~-TACACATACT GGGCT T GT GGCGT GAT CCT CAT CAT CGC.AGGCCT CTACCT ~ ~T T ~AT ~ T  ~ A T  ~ 
D Y K Y T ¥. W A C G V I L I Z A G L Y L F 1 G M G I N Y I% L 440 
1532 GT GGCC_~_~_ a - G A T G T T G A T Q , ~  
V A K E Q+ K A E E K K R D G K E D E T 8 T D V D E K P K K T 470 
1622 A T ~  ~ G C ,  A G A A C A G C T C T ~ C T  GACCTGTGGAGCATGAA 
M K E T Q 8 P A P L Q N 8 8 G D P A E E E 8 P V 494 
1712 GAGAGCAGGTGT ~TCCGAAACCATTCTGt~GGCCTCTA~TCT~GGT GCTCCGTGCA(3kCAGT GGACAT~I"TGTGT G
1802 (Ea-a-~-~-CCCACCAGGT GT T CAT T GGT GGGAT TT T T TTT TTT  CACT CCTTACCAAT GCCTGGATTT.~_a_I_L.TAT~ ~ ~ T ~ ~  
1892 GTGGTTGACAAAGAATAT GATCTGTTTGTT TGTTTGTTT GTTTGTTTGTTTGTTTTAATCTTAGCT TTACAGTGT 
1982 CAT GAAGAT TATAATAT GT GCCTTAAGTT T TAGT T T TTAGAACT CT T TAGAGAGCCTTAACTT T T.a_~_~_~.CCATT CT ~ ~ T  T ~T ~ G 
2072 TTTAAAACGTCATTTT TAACAACTAGCTTGCTTGAGGTAACTAACCTTAATCTTGTTTTGTTGTTGTTGTAATGCTTTG 
2162 T ~ T GTTACCGGAACAT TAT  GAATAGAAATACT GCT TAAAGGT~-~-~ATAAAATACT GACT_L_L_L_qTATTTTT CTA 
2252 GCATTATAGTTGCCTGGTAC.ATCTGCTGCTAGGTATATATTTGAGAAATTTGAAGCATAAAATTCT G G A T C T T ~ ~  
2342 CCTGTCACCTGCTGGGC, ACCTCTTCTGGAATGCTCACTACAGTCTAGT CTAAGGTGTTGCCACTGAATTGAT~~A~ 
2432 ~ GT GT GGTTAGAAGTAAT  GGCCATTTTT  (3AAAT CAAAT GC_L_L_~_L_L_~TTAGTATT_~_L~_T ~ ~ ~  ~ ~ G  
2522 T CTGATTTAATGTAAACAGTAT  T CAAGCAT CAGCT GAATT ~AGGTTGT CCC-~-L_z_L.CCTTAGT TAT GGT ~ T ~ A T  
2612 GTGTGGGTTTGAGGGGCT GT GAGT GAGGTCTTGGTTCTTAGGATT TGAGCATG( : (3AAGTACAT~AC(R3CC(3~QC 
2702 C J%C-~GGAGTCCTCCTAGTCCCTGA~ACCTTTTCTCTGATTTTTGATAGCTCATTTATTT~AGTTTAGAGC 
2792 T GTATGT GAGATAT CCAGTACAGGGTGAATGTATGCGCTCTTT G TTTTTACATTGTTTT CA(;TATTTGC-~-~_ ~ CAGTGT 
2882 TTGGCCT TAAAGATAAAATAGGGTGGAAGTTTGCAGACTTTCAGTAAGTACCCACCT ~ AGGCTT 
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Rat MPPAIGGPVGYTPPDGGWGWAVVVGAFISIGFSYAFPKSITVFFKEIEIIFIATTSEVSWISSIMLAVMYAGGPI 75 
CHO MPPAIGGPVGYTPPDGGWGWAVVVGAFISIGFSYAFPKSITVFFKEIEGIFIATTSEVSWISSIMLAVMYAGGPI 75 
Human MPPAIGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFIATTSEVSWISSIMLAVMYIGGPI 75 
Rat SSILVNKYGSRPVMIAGGCLSGCGLIAASFCNTVQELYICIGVIGGLGLAFNLNPALTMIGKYFYKKRPLANGLA 150 
CHO SSILVNKYGSRPVMIAGGCLSGCGLIAASFCNTVOELYmCIGVlGGLGLAFNLNPALTM1GKYFYKKRPLANGLA 160 
Human SSILVNKYGSRIVMIIGGCLSGCGLIAASFCNTVQILYICIGVlGGLGLAFNLNPALTMIGKYFYKIRPLANGLA 150 
Rat MAGSPVFLSTLAPLNOAFFGIFGWRGSFLILGGLLLNCCVAGSLMRPIGPIGKIEKLKSKESLQEAQKS . . . . . 221 
CHO MAGSPVFLSTLAPLNQAFFGIFGWRGSFL1LGGLLLNCCVAGSLMRPIGPKPGKIEKLKSKESLQEAGKS . . . . .  221 
Human MAGSPVFLITLAPLNOIFFGIFGWRGSFLILGGLLLNCCVAGILMRPIGPKPIKIKIKSKISLIAGK I 225 
Rat 
CHO 
Human 
--DANTDLIGGSPKGEKISVFQTINKFLDLSLFTHRGFLLYLSGNVVMFFGLFTPLVFLSNYGKS~HISSEKSAF 293 
--~ANTDLIGGSPKGEKRSVIQTINKFLDLSLFIHRGFLLYLSGNVVMFFGLFTPLVFLSNYGKSQHYSSEKSAF 293 
IIDANTDL1GIPKIEKRSVFQTINIFLDLILFTHRGFLLYLSGNVIMFFGLFIPLVFLS~YGKSOHYSSEKSAF 300 
Rat 
CHO 
Human 
LLSILAFVDMVARPSMGLAANTIWIRPRIQYFFAASVVANGVCHLLAPLSTTYVGFCIYAGVFGFAFGWLSSVLF 368 
LLSILAFVDMVARPSMGLAANTKWIRPRIQYFFAASVVANGVCHLLAPLSTIYIGFCIYAGVFGFAFGWLSSVLF 368 
LLSILAFVDMVARPSMGLIANTKIIRPRIQYFFAASVVANGVCHILAPLSTTYVGFCIYAGIFGFAFGWLSSVLF 375 
Rat 
CHO 
Human 
ETLMDLVGPORFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVILIIAGIYLFIGMGINYRLVAK qq3 
ETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVlLIIAGIYLF[GMGINYRLVAK qq3 
ETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYKYTYWACGVILIIIGIYLFIGMGINYRLIAK qso 
Rat EOKAEEKKI-- IGKEDETSTOVOEKPKIKITIsPIQNSSGDPAEEESPV. 495 
CHO EQKAEEKI[~GKEDITSTDVOEKPKEI~KITEsPF--QNSSQDPAEEESPV 495 
H u m a n EQ K A~EIKK ---- EIK ErE T S~D VIK PIEI T K IE SP I - IG IP I  E E E SP V 501 
Fig. 2. Alignment of the protein sequences of rat, CHO and human MCT1. Alignments were performed using Megalign software (DNAStar) with the 
Clustal algorithm (gap penalty = 10, gap length penalty = 10). Residues which are not identical in all three sequences are highlighted. 
and cDNA was synthesised using AMV reverse transcrip- 
tase with oligo(dT) priming. PCR was performed for 35 
cycles using standard conditions with exact match primers 
flanking the coding region of the CHO sequence. A single 
band of the predicted size (1500 bp) was obtained. The 
purified PCR product was labelled with [ o/-32 P]dCTP by 
random priming (Amersham Multiprime Kit). The probe 
was then purified by gel filtration (Pharmacia Nick Col- 
umn) and used to screen a rat skeletal muscle Uni-ZAP 
XR library (Stratagene, La Jolla, CA, USA). Putative 
positive clones obtained from screening approximately 1 • 
l 0  6 recombinant phage were then subjected to two further 
rounds of screening until plaque purity was achieved. The 
pBluescript phagemids were then excised using the ExAs- 
sist helper phage as described by Stratagene. Initial charac- 
terisation of the inserts by multiple restriction digests 
showed that several of the clones were identical, both in 
size and restriction pattern and thus were likely to be 
sibling clones. Initial sequencing of the 3' and 5' ends of 
one insert showed it to be very similar to the correspond- 
ing non-coding regions of CHO MCT1. This 3.3 kb insert 
was then sequenced on both strands using a custom primer 
walking strategy on a Du Pont Genesis 2000 automated 
sequencer. 
The complete cDNA and deduced amino acid sequence 
obtained are presented in Fig. 1. The sequence contains an 
open reading frame encoding 494 amino acids. This pre- 
dicts a polypeptide of 53 kDa having 12 putative trans- 
membrane spanning regions. In MCT1 purified from rabbit 
erythrocytes, the N-terminal sequence of the mature pro- 
tein corresponds to this predicted ORF, except that the 
initiator methionine is removed, and there is an isoleucine 
to valine substitution at position five [10]. 
The 3295 bp long cDNA contains 211 bp of 5' non-cod- 
ing sequence and 1597 bp of 3' non-coding sequence. 
During the course of this work, the sequence of human 
MCT1 was also published [11]. Overall the rat nucleotide 
sequence has 89% identity with CHO MCT1, and 83% 
identity with human MCTI.  
The derived amino acid sequence of rat MCTl has 94% 
and 86% identity with CHO and human MCT1, respec- 
tively. Fig. 2 shows an alignment of the predicted amino 
acid sequences. As expected the sequences have the high- 
est degree of homology within the predicted membrane- 
spanning regions. Unlike CHO MCTI,  the rat and human 
sequences do not possess a potential site for N-linked 
glycosylation (Asn-X-Ser/Thr); Asparagine 52 is replaced 
by serine in rat and histidine in the human sequence. 
Fig. 1. Nucleotide and deduced amino acid sequences of rat MCTI cDNA. Numbers on the left refer to nucleotides, while those on the right refer to the 
amino acids. The underlined regions of the protein sequence denote the predicted transmembrane regions, assigned on the basis of hydrophobicity. 
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However, despite the presence of this consensus motif, 
recent experimental results show that the CHO MCTI 
protein is not glycosylated [12]. 
The deduced amino acid sequence of rat MCT1 will 
allow site directed mutations to be generated. These may 
help to identify those residues responsible for the catalytic 
mechanism of monocarboxylate ransport and also those 
residues which confer substrate and inhibitor specificity. 
Mutation of phenylanine 360 to cysteine in transmembrane 
region ten of CHO MCT1 causes a gain of function 
allowing transport of mevalonate [8]. This region is thus 
intimately involved in the transport process. This phenyl- 
alanine is present at the same position within transmem- 
brane region 10 in all of the MCTI sequences i olated so 
far. 
Recently a cDNA encoding a second monocarboxylate 
transporter isoform, MCT2, was cloned from hamster liver 
[9]. This cDNA has also been shown to be expressed in 
oxidative skeletal muscle, but not in white skeletal muscle, 
as is the case for MCT1. Thus it is likely that another 
isoform of MCT exists in the glycolytic fast twitch fibres. 
The rat MCT1 cDNA isolated in this study is likely to 
derive from red muscle present in the mixed muscle fibres 
of the hind limb tissue used to generate the library. 
Studies are currently under way to isolate an MCT 
isoform from white skeletal muscle fibres. We are also 
characterising several other clones from the mixed fibre 
library which appear to be different from MCTI. 
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